Medical News

RSS

A decade of CCBHCs enhances access to mental health care across the U.S.

A decade after the establishment of the certified community behavioral health clinic (CCBHC) model, more than 60 percent of the US population has access to such facilities and the mental health and substance use disorder treatment services they provide, according to a new study led by researchers at the NYU School of Global Public Health.

4 Oct 2024

New insights into the role of gamma-delta T cells across 33 cancer types revealed

A new study published in Cell Press reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer treatment.

4 Oct 2024

Breakthrough blood test improves early diagnosis of pancreatic cancer

An experimental blood test detects early-stage pancreatic cancer more effectively than other available tests, reports a new study published in Cancer Letters.

4 Oct 2024

Study unravels the unique patterns of brain shrinkage in Alzheimer's disease

The way in which brains shrink in those who develop Alzheimer's disease follows no specific or uniform pattern, finds a new study by researchers at UCL and Radboud University in the Netherlands.

4 Oct 2024

New X-ray technique reveals metal ion role in antibiotic efficacy

Researchers from City St George's, University of London have used a new ultra-high precision x-ray scattering technique to unveil the location and identity of metal ions in bacteria that are crucial for antibiotics to work optimally.

4 Oct 2024

WHO lists first mpox in vitro diagnostic test under Emergency Use Listing

The World Health Organization (WHO) has listed the first mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure, an important step in improving global access to mpox testing.

4 Oct 2024

Identical twins study uncovers insights into multiple sclerosis mechanisms

Multiple sclerosis (MS) is a chronic inflammatory disease in which the immune system attacks the central nervous system.

4 Oct 2024

LXRβ emerges as a promising target for depression and anxiety treatments

In a state-of-the-art Bench to Bedside review published in the journal Brain Medicine (Genomic Press), researchers Dr. Xiaoyu Song and Professor Jan-Åke Gustafsson from the University of Houston and Karolinska Institutet (Sweden) shed light on the therapeutic potential of liver X receptor beta (LXRβ) in treating depression and anxiety.

4 Oct 2024

Imagery rescripting offers new hope for treating hoarding disorder

Rehearsing alternative outcomes of discarding through imagery rescripting shows promise as a treatment strategy for people who hoard, a study by UNSW psychology researchers has shown.

4 Oct 2024

Greater bean and pulse intake linked to improved nutrient intake and diet quality in American adults

New research showing the association between greater bean and pulse consumption and improved shortfall nutrient intakes and a higher diet quality in American adults will be presented during the Academy of Nutrition and Dietetics (the Academy) Food & Nutrition Conference & Expo (FNCE) 2024 in Minneapolis, MN.

4 Oct 2024

Researchers unveil complete neuronal map of fruit fly brain

Researchers map the whole brain of Drosophila melanogaster, or the fruit fly, which comprises about 140,000 neurons and over 50 million synapses.

4 Oct 2024

The true death toll of hurricanes in the U.S.

Researchers investigate the excess mortality associated with tropical cyclones in the contiguous United States.

4 Oct 2024

Thousands could have been saved during the pandemic with expanded use of convalescent plasma

A new study led by researchers at Johns Hopkins Bloomberg School of Public Health estimates that thousands of lives could have been saved during the first year of the COVID-19 pandemic if convalescent plasma had been used more broadly, particularly in outpatients at high risk for severe disease and in hospitalized patients during their first few days of admission.

4 Oct 2024

Study paves way to more efficient non-addictive treatment for chronic pain

Researchers at Karolinska Institutet in Sweden have developed a new comprehensive mapping of genetic activity for understanding the causes of chronic pain.

4 Oct 2024

Trump leads, and his party follows, on vaccine skepticism

More than four years ago, former President Donald Trump’s administration accelerated the development and rollout of the covid-19 vaccine.

4 Oct 2024

Study reveals impact of smoking elimination on global life expectancy

Accelerating the decline in tobacco smoking globally, by decreasing smoking prevalence from current levels to 5% everywhere, could increase life expectancy and prevent millions of premature deaths by 2050, according to a study from the Global Burden of Disease, Injuries and Risk Factors (GBD) Tobacco Forecasting Collaborators published in The Lancet Public Health journal.

4 Oct 2024

Here’s why getting a covid shot during pregnancy is important

Nearly 90% of babies who had to be hospitalized with covid-19 had mothers who didn't get the vaccine while they were pregnant, according to new data released by the Centers for Disease Control and Prevention.

4 Oct 2024

Research links arts and culture participation to improved wellbeing in young people

The wellbeing of young people in the UK has significantly decreased in the last two decades with a major international study ranking the UK’s young people fourth from bottom out of 74 countries in terms of life satisfaction.

4 Oct 2024

Owkin partners with AstraZeneca to enhance gBRCA testing for breast cancer

Owkin, the first end-to-end AI-biotech that uses cutting-edge causal AI to unlock precision drug discovery, development and diagnostics, is pleased to announce a new partnership with AstraZeneca, a global biopharmaceutical company, to develop an AI-powered tool to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides.

4 Oct 2024

Myogenes Clozapine Test promises to improve outcomes for schizophrenia patients

Myogenes, a leading innovator in genetic testing, has been awarded a grant from Innovate UK, the UK’s innovation agency, to further develop its revolutionary Myogenes Clozapine Test for treatment-resistant schizophrenia (TRS). This cutting-edge genetic analysis tool promises to dramatically improve patient care and generate substantial cost savings for the NHS.

4 Oct 2024